CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate bargaining power of buyers
3.3.3. Moderate threat of substitutes
3.3.4. Moderate threat of new entrants
3.3.5. Moderate intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the prevalence of neurological disorders in children
3.4.1.2. Increase in government funding to support development activities for invention of new medical devices
3.4.1.3. Changing lifestyles led by growing industrialization and urbanization
3.4.2. Restraints
3.4.2.1. High cost associated with diagnosis and treatment monitoring of neurological disorders
3.4.3. Opportunities
3.4.3.1. Rise in awareness regarding the benefits of pediatric neurology devices
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Neurostimulation Devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Neurosurgery Devices
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Interventional Neurology Devices
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Cerebrospinal Fluid Management Devices
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Others
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
CHAPTER 5: PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION
5.1. Overview
5.1.1. Market size and forecast
5.2. Stroke
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Seizures
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Hydrocephalus
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Oncology
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP
6.1. Overview
6.1.1. Market size and forecast
6.2. 0-5 Years
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. 5-10 Years
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. 10-15 Years
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Hospitals
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Ambulatory surgery centers
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Others
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: PEDIATRIC NEUROLOGY DEVICE MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Product Type
8.2.3. Market size and forecast, by Condition
8.2.4. Market size and forecast, by Age group
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Product Type
8.2.6.1.3. Market size and forecast, by Condition
8.2.6.1.4. Market size and forecast, by Age group
8.2.6.1.5. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Product Type
8.2.6.2.3. Market size and forecast, by Condition
8.2.6.2.4. Market size and forecast, by Age group
8.2.6.2.5. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Product Type
8.2.6.3.3. Market size and forecast, by Condition
8.2.6.3.4. Market size and forecast, by Age group
8.2.6.3.5. Market size and forecast, by End User
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Product Type
8.3.3. Market size and forecast, by Condition
8.3.4. Market size and forecast, by Age group
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Product Type
8.3.6.1.3. Market size and forecast, by Condition
8.3.6.1.4. Market size and forecast, by Age group
8.3.6.1.5. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Product Type
8.3.6.2.3. Market size and forecast, by Condition
8.3.6.2.4. Market size and forecast, by Age group
8.3.6.2.5. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Product Type
8.3.6.3.3. Market size and forecast, by Condition
8.3.6.3.4. Market size and forecast, by Age group
8.3.6.3.5. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Product Type
8.3.6.4.3. Market size and forecast, by Condition
8.3.6.4.4. Market size and forecast, by Age group
8.3.6.4.5. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Product Type
8.3.6.5.3. Market size and forecast, by Condition
8.3.6.5.4. Market size and forecast, by Age group
8.3.6.5.5. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Product Type
8.3.6.6.3. Market size and forecast, by Condition
8.3.6.6.4. Market size and forecast, by Age group
8.3.6.6.5. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Product Type
8.4.3. Market size and forecast, by Condition
8.4.4. Market size and forecast, by Age group
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. China
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Product Type
8.4.6.1.3. Market size and forecast, by Condition
8.4.6.1.4. Market size and forecast, by Age group
8.4.6.1.5. Market size and forecast, by End User
8.4.6.2. Japan
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Product Type
8.4.6.2.3. Market size and forecast, by Condition
8.4.6.2.4. Market size and forecast, by Age group
8.4.6.2.5. Market size and forecast, by End User
8.4.6.3. India
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Product Type
8.4.6.3.3. Market size and forecast, by Condition
8.4.6.3.4. Market size and forecast, by Age group
8.4.6.3.5. Market size and forecast, by End User
8.4.6.4. Australia
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Product Type
8.4.6.4.3. Market size and forecast, by Condition
8.4.6.4.4. Market size and forecast, by Age group
8.4.6.4.5. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Product Type
8.4.6.5.3. Market size and forecast, by Condition
8.4.6.5.4. Market size and forecast, by Age group
8.4.6.5.5. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Product Type
8.4.6.6.3. Market size and forecast, by Condition
8.4.6.6.4. Market size and forecast, by Age group
8.4.6.6.5. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Product Type
8.5.3. Market size and forecast, by Condition
8.5.4. Market size and forecast, by Age group
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Product Type
8.5.6.1.3. Market size and forecast, by Condition
8.5.6.1.4. Market size and forecast, by Age group
8.5.6.1.5. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Product Type
8.5.6.2.3. Market size and forecast, by Condition
8.5.6.2.4. Market size and forecast, by Age group
8.5.6.2.5. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Product Type
8.5.6.3.3. Market size and forecast, by Condition
8.5.6.3.4. Market size and forecast, by Age group
8.5.6.3.5. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Product Type
8.5.6.4.3. Market size and forecast, by Condition
8.5.6.4.4. Market size and forecast, by Age group
8.5.6.4.5. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2021
CHAPTER 10: COMPANY PROFILES
10.1. Integra LifeSciences Holdings
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.1.7. Key strategic moves and developments
10.2. B.Braun SE
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.3. Medtronic plc
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.3.7. Key strategic moves and developments
10.4. Natus Medical Incorporated
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.4.7. Key strategic moves and developments
10.5. Stryker Corporation
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.6. Boston Scientific Corporation
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.7. Abbott Laboratories
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.7.7. Key strategic moves and developments
10.8. LivaNova PLC
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.8.7. Key strategic moves and developments
10.9. Zimmer Biomet Holding Inc.
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.9.7. Key strategic moves and developments
10.10. KARL STORZ SE & Co. KG
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
TABLE 01. GLOBAL PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 02. PEDIATRIC NEUROLOGY DEVICE MARKET FOR NEUROSTIMULATION DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 03. PEDIATRIC NEUROLOGY DEVICE MARKET FOR NEUROSURGERY DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 04. PEDIATRIC NEUROLOGY DEVICE MARKET FOR INTERVENTIONAL NEUROLOGY DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 05. PEDIATRIC NEUROLOGY DEVICE MARKET FOR CEREBROSPINAL FLUID MANAGEMENT DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 06. PEDIATRIC NEUROLOGY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 07. GLOBAL PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 08. PEDIATRIC NEUROLOGY DEVICE MARKET FOR STROKE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 09. PEDIATRIC NEUROLOGY DEVICE MARKET FOR SEIZURES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. PEDIATRIC NEUROLOGY DEVICE MARKET FOR HYDROCEPHALUS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 11. PEDIATRIC NEUROLOGY DEVICE MARKET FOR ONCOLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. PEDIATRIC NEUROLOGY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 13. GLOBAL PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 14. PEDIATRIC NEUROLOGY DEVICE MARKET FOR 0-5 YEARS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 15. PEDIATRIC NEUROLOGY DEVICE MARKET FOR 5-10 YEARS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 16. PEDIATRIC NEUROLOGY DEVICE MARKET FOR 10-15 YEARS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 17. GLOBAL PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 18. PEDIATRIC NEUROLOGY DEVICE MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. PEDIATRIC NEUROLOGY DEVICE MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 20. PEDIATRIC NEUROLOGY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 21. PEDIATRIC NEUROLOGY DEVICE MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 22. NORTH AMERICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 23. NORTH AMERICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 24. NORTH AMERICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 25. NORTH AMERICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 26. NORTH AMERICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 27. U.S. PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 28. U.S. PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 29. U.S. PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 30. U.S. PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 31. CANADA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 32. CANADA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 33. CANADA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 34. CANADA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 35. MEXICO PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 36. MEXICO PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 37. MEXICO PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 38. MEXICO PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 39. EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 40. EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 41. EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 42. EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 43. EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 44. GERMANY PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 45. GERMANY PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 46. GERMANY PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 47. GERMANY PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 48. FRANCE PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 49. FRANCE PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 50. FRANCE PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 51. FRANCE PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 52. UK PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 53. UK PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 54. UK PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 55. UK PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 56. ITALY PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 57. ITALY PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 58. ITALY PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 59. ITALY PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 60. SPAIN PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 61. SPAIN PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 62. SPAIN PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 63. SPAIN PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 64. REST OF EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 65. REST OF EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 66. REST OF EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 67. REST OF EUROPE PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 68. ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 69. ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 70. ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 71. ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 72. ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 73. CHINA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 74. CHINA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 75. CHINA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 76. CHINA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 77. JAPAN PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 78. JAPAN PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 79. JAPAN PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 80. JAPAN PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 81. INDIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 82. INDIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 83. INDIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 84. INDIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 85. AUSTRALIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 86. AUSTRALIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 87. AUSTRALIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 88. AUSTRALIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 89. SOUTH KOREA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 90. SOUTH KOREA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 91. SOUTH KOREA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 92. SOUTH KOREA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 93. REST OF ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 94. REST OF ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 95. REST OF ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 96. REST OF ASIA-PACIFIC PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 97. LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 98. LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 99. LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 100. LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 101. LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 102. BRAZIL PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 103. BRAZIL PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 104. BRAZIL PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 105. BRAZIL PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 106. SAUDI ARABIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 107. SAUDI ARABIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 108. SAUDI ARABIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 109. SAUDI ARABIA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 110. SOUTH AFRICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 111. SOUTH AFRICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 112. SOUTH AFRICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 113. SOUTH AFRICA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 114. REST OF LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 115. REST OF LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION, 2021-2031 (REVENUE, $MILLION)
TABLE 116. REST OF LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
TABLE 117. REST OF LAMEA PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 118. INTEGRA LIFESCIENCES HOLDINGS: KEY EXECUTIVES
TABLE 119. INTEGRA LIFESCIENCES HOLDINGS: COMPANY SNAPSHOT
TABLE 120. INTEGRA LIFESCIENCES HOLDINGS: PRODUCT SEGMENTS
TABLE 121. INTEGRA LIFESCIENCES HOLDINGS: PRODUCT PORTFOLIO
TABLE 122. INTEGRA LIFESCIENCES HOLDINGS: KEY STRATERGIES
TABLE 123. B.BRAUN SE: KEY EXECUTIVES
TABLE 124. B.BRAUN SE: COMPANY SNAPSHOT
TABLE 125. B.BRAUN SE: PRODUCT SEGMENTS
TABLE 126. B.BRAUN SE: PRODUCT PORTFOLIO
TABLE 127. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 128. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 129. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 130. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 131. MEDTRONIC PLC: KEY STRATERGIES
TABLE 132. NATUS MEDICAL INCORPORATED: KEY EXECUTIVES
TABLE 133. NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
TABLE 134. NATUS MEDICAL INCORPORATED: PRODUCT SEGMENTS
TABLE 135. NATUS MEDICAL INCORPORATED: PRODUCT PORTFOLIO
TABLE 136. NATUS MEDICAL INCORPORATED: KEY STRATERGIES
TABLE 137. STRYKER CORPORATION: KEY EXECUTIVES
TABLE 138. STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 139. STRYKER CORPORATION: PRODUCT SEGMENTS
TABLE 140. STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 141. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 142. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 143. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
TABLE 144. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 145. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 146. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 147. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 148. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 149. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 150. LIVANOVA PLC: KEY EXECUTIVES
TABLE 151. LIVANOVA PLC: COMPANY SNAPSHOT
TABLE 152. LIVANOVA PLC: PRODUCT SEGMENTS
TABLE 153. LIVANOVA PLC: PRODUCT PORTFOLIO
TABLE 154. LIVANOVA PLC: KEY STRATERGIES
TABLE 155. ZIMMER BIOMET HOLDING INC.: KEY EXECUTIVES
TABLE 156. ZIMMER BIOMET HOLDING INC.: COMPANY SNAPSHOT
TABLE 157. ZIMMER BIOMET HOLDING INC.: PRODUCT SEGMENTS
TABLE 158. ZIMMER BIOMET HOLDING INC.: PRODUCT PORTFOLIO
TABLE 159. ZIMMER BIOMET HOLDING INC.: KEY STRATERGIES
TABLE 160. KARL STORZ SE & CO. KG: KEY EXECUTIVES
TABLE 161. KARL STORZ SE & CO. KG: COMPANY SNAPSHOT
TABLE 162. KARL STORZ SE & CO. KG: PRODUCT SEGMENTS
TABLE 163. KARL STORZ SE & CO. KG: PRODUCT PORTFOLIO
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
